AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

GERON CORP Director's Dealing 2013

Oct 9, 2013

32370_dirs_2013-10-09_2f458759-2e10-45e6-b7d1-7b5f177189f2.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Asterias Biotherapeutics, Inc. (NONE)
CIK: 0001572552
Period of Report: 2013-10-01

Reporting Person: GERON CORP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Series A Common Stock	6537779	Direct

Footnotes

F1: See Exhibit 99.1